Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tianjin Tianyao Pharmaceutical CoSHSE:600488 -3.72%56 Interest Coverage is 11.15 as of Mar. 2026, which is 5% above its 10-year median of 10.58. GuruFocus rates SHSE:600488 with a GF Score™ of 56/100 and a GF Value™ of ¥3.59 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 687 Drug Manufacturers companies, Tianjin Tianyao Pharmaceutical Co ranks worse than 50.22% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Tianjin Tianyao Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥54 Mil. Tianjin Tianyao Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-5 Mil.
Tianjin Tianyao Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 11.15.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Tianjin Tianyao Pharmaceutical Co's Interest Coverage or its related term are showing as below:
SHSE:600488'
s Interest Coverage Range Over the Past 10 Years
Min: 5.12 Med: 10.58 Max: 21.08
Current: 12.7
SHSE:600488's Interest Coverage is ranked worse than 50.22% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SHSE:600488: 12.70
Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Tianjin Tianyao Pharmaceutical Co Interest Coverage Related Terms
Tianjin Tianyao Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Tianjin Tianyao Pharmaceutical Co Interest Coverage Chart
SHSE:600488 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Tianyao Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tianjin Tianyao Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tianjin Tianyao Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Tianjin Tianyao Pharmaceutical Co's Interest Coverage falls into.
Tianjin Tianyao Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Tianyao Pharmaceutical Co (SHSE:600488) has a Interest Coverage of 11.15 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. This is near median its historical median of 10.58. Over the past decade, Tianjin Tianyao Pharmaceutical Co's Interest Coverage has ranged from 5.12 to 21.08. According to the industry distribution chart, Tianjin Tianyao Pharmaceutical Co ranks #345 out of 687 companies in the Drug Manufacturers industry, placing it in the top 50.2%.
Is Tianjin Tianyao Pharmaceutical Co's Interest Coverage too high?
Tianjin Tianyao Pharmaceutical Co's current Interest Coverage of 11.15 is near median its 10-year median of 10.58. Over the past 10 years, this metric has ranged from a low of 5.12 to a high of 21.08. The Drug Manufacturers industry median Interest Coverage is 12.75. Tianjin Tianyao Pharmaceutical Co's value of 11.15 is 12.5% below this industry median. Based on the distribution chart, Tianjin Tianyao Pharmaceutical Co ranks #345 out of 687 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Tianjin Tianyao Pharmaceutical Co has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Tianyao Pharmaceutical Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Tianjin Tianyao Pharmaceutical Co ranks #345 out of 687 companies for Interest Coverage. This places Tianjin Tianyao Pharmaceutical Co in the lower half of its industry. The industry median Interest Coverage is 12.75. Tianjin Tianyao Pharmaceutical Co's value of 11.15 is 12.5% below this benchmark. Historically, Tianjin Tianyao Pharmaceutical Co's own Interest Coverage has ranged from 5.12 to 21.08 over the past decade. While the company's 10-year median is 10.58 vs. the industry median of 12.75, Tianjin Tianyao Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tianjin Tianyao Pharmaceutical Co's current Interest Coverage of 11.15 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tianjin Tianyao Pharmaceutical Co's current Interest Coverage is 11.15, which is near median its own 10-year median of 10.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Tianyao Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co (SHSE:600488) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.59, compared to a current price of ¥6.72 — trading 87.2% above its estimated fair value. The current Interest Coverage is 11.15, which is near median its 10-year median of 10.58 and 12.5% below the Drug Manufacturers industry median of 12.75. Tianjin Tianyao Pharmaceutical Co's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Tianjin Tianyao Pharmaceutical Co (SHSE:600488), the current Interest Coverage is 11.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Overvalued in 2026?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥6.72 is trading 87.2% above its estimated GF Value™ of ¥3.59.
GuruFocus considers Tianjin Tianyao Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:600488:
Interest Coverage: 11.15 (near median its 10-year median of 10.58)
GF Value™: ¥3.59 vs. price of ¥6.72 (87.2% above fair value)
Industry Position: 12.5% below the Drug Manufacturers median (#345 of 687)
No single metric tells the full story. See the SHSE:600488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tianjin Tianyao Pharmaceutical Co Business Description
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
56GF Score
Get the complete analysis for SHSE:600488
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600488 has been successfully added to your 
